Table 1.
Transcriptome datasets used in this study. The number of samples selected reflect the samples chosen post normalisation and clustering in each condition
| ID | Dataset | Platforms | Samples and condition studied | Population cohort | Reference |
|---|---|---|---|---|---|
| TB_1 | GSE28623 | Agilent | Whole blood from 46 TB and 37 HC | The Gambia | 23 |
| TB_2 | GSE34608 | Agilent | Whole blood samples: 8 TB, 18 HC, and 16 Sarcoidosis | Germany | 24 |
| TB_3 | GSE56153 | Illumina | Whole blood samples: 18 TB and 18 HC | London | 25 |
| TB_4 | GSE19491 | Illumina | Whole blood samples: 56 TB, 30 HC, 29 Still’s disease, 28 ASLE | UK, SA | 21 |
| TB_5 | GSE42834 | Agilent | Whole blood samples: 35 TB, 62 HC, and 13 pneumonia samples | London | 22 |
| TB_0, TB_2w, TB_2m, TB_4m, TB_6m | GSE40553 | Illumina | Whole blood samples: 27 TB patients monitored at diagnosis, 2 weeks, 2 months, 4 months and 6 months post treatment. | SA | 40 |